299 related articles for article (PubMed ID: 18290505)
1. [Graves disease in pregnancy a risk for the child. Maternal TSH receptor antibodies can cause fetal and neonatal thyrotoxicosis].
Roos M; Sjöberg O; Axelsson O; Karlsson FA
Lakartidningen; 2008 Jan 16-22; 105(3):120-4. PubMed ID: 18290505
[No Abstract] [Full Text] [Related]
2. Risk factors for developmental disorders in infants born to women with Graves disease.
Mitsuda N; Tamaki H; Amino N; Hosono T; Miyai K; Tanizawa O
Obstet Gynecol; 1992 Sep; 80(3 Pt 1):359-64. PubMed ID: 1379702
[TBL] [Abstract][Full Text] [Related]
3. [Thyroid stimulating antibodies in pregnant women with Graves' disease and neonatal thyrotoxicosis].
Nygaard B; Petersen JR; Jespersen NF
Ugeskr Laeger; 1997 Feb; 159(8):1086-9. PubMed ID: 9072852
[TBL] [Abstract][Full Text] [Related]
4. [Neonatal hyperthyroidism in a premature infant born to a mother with Grave's disease].
Nicaise C; Gire C; Brémond V; Minodier P; Soula F; d'Ercole C; Palix C
Arch Pediatr; 2000 May; 7(5):505-8. PubMed ID: 10855389
[TBL] [Abstract][Full Text] [Related]
5. Epitope mapping of tsh receptor-blocking antibodies in Graves' disease that appear during pregnancy.
Kung AW; Lau KS; Kohn LD
J Clin Endocrinol Metab; 2001 Aug; 86(8):3647-53. PubMed ID: 11502791
[TBL] [Abstract][Full Text] [Related]
6. [Hyperthyroidism in a premature infant due to transplacental passage of maternal thyrotropin receptor antibodies].
Rink T; Wieg C; Schroth HJ; Helisch A; Bertram U
Nuklearmedizin; 1999; 38(5):156-9. PubMed ID: 10488483
[TBL] [Abstract][Full Text] [Related]
7. [Development of neonatal Graves' disease--prediction, prevention and treatment].
Matsuura N
Nihon Rinsho; 2006 Dec; 64(12):2303-7. PubMed ID: 17154096
[TBL] [Abstract][Full Text] [Related]
8. [Guidelines for measurement of TSH receptor antibodies in pregnant women. Results from an evidence based symposium organized by the European Thyroid Society].
Nygaard B; Laurberg P; Glinoer D; Grussendorf M; Orgiazzi J
Ugeskr Laeger; 1999 Nov; 161(44):6037-8. PubMed ID: 10778336
[No Abstract] [Full Text] [Related]
9. [Spontaneous hypothyroidism in 4 patients with Graves-Basedow disease].
González-González A; Recio Cordova JM; Aznar Ondoño I; Del Monte Jarabo Bueno M
Endocrinol Nutr; 2009 May; 56(5):273-6. PubMed ID: 19627750
[TBL] [Abstract][Full Text] [Related]
10. Thyrotropin receptor antibodies associated with post-operative relapse of thyrotoxicosis in a pregnancy complicated by neonatal thyrotoxicosis.
Wilson R; Fraser WD; Gray CE; Alroomi LG; Thomson JA
Scott Med J; 1990 Feb; 35(1):21-2. PubMed ID: 2315685
[TBL] [Abstract][Full Text] [Related]
11. [Fetal and neonatal thyrotoxicosis are severe conditions in which diagnosis can be overlooked].
Gustafsson J; Ewald U; Westermark K; Karlsson A
Lakartidningen; 1991 Feb; 88(7):519-20. PubMed ID: 2000004
[No Abstract] [Full Text] [Related]
12. Maternal Thyrotropin Receptor Antibody Concentration and the Risk of Fetal and Neonatal Thyrotoxicosis: A Systematic Review.
van Dijk MM; Smits IH; Fliers E; Bisschop PH
Thyroid; 2018 Feb; 28(2):257-264. PubMed ID: 29325496
[TBL] [Abstract][Full Text] [Related]
13. Third-Generation Thyrotropin Receptor Antibody (TRAb) assay for predicting neonatal thyroid dysfunction in pregnant women with Graves' disease.
Priyanka R; Sridhar S; Sumathi B; Jeyaraj AR; Natarajan V; Subbiah E; Raghavan KS; Sangumani J
Endocrine; 2024 May; 84(2):500-508. PubMed ID: 37861945
[TBL] [Abstract][Full Text] [Related]
14. [Fetal and neonatal outcomes in infants of mothers with TSH receptor antibody positivity in pregnancy].
Zuppa AA; Perrone S; Sindico P; Alighieri G; Antichi E; Carducci C; Romagnoli C
Pediatr Med Chir; 2009; 31(2):72-7. PubMed ID: 19642499
[TBL] [Abstract][Full Text] [Related]
15. [Neonatal hyperthyroidism caused by TSH receptor antibodies in maternal autoimmune hyperthyroidism].
Resch B; Mache C; Rosegger H; Häusler M
Z Geburtshilfe Neonatol; 1995; 199(6):248-52. PubMed ID: 8581851
[TBL] [Abstract][Full Text] [Related]
16. Neonatal thyrotoxicosis and conjugated hyperbilirubinemia.
Beroukhim RS; Moon TD; Felner EI
J Matern Fetal Neonatal Med; 2003 Jun; 13(6):426-8. PubMed ID: 12962270
[TBL] [Abstract][Full Text] [Related]
17. Relevance of TSH receptor stimulating and blocking autoantibody measurement for the prediction of relapse in Graves' disease.
Schott M; Minich WB; Willenberg HS; Papewalis C; Seissler J; Feldkamp J; Bergmann A; Scherbaum WA; Morgenthaler NG
Horm Metab Res; 2005 Dec; 37(12):741-4. PubMed ID: 16372227
[TBL] [Abstract][Full Text] [Related]
18. Comparison of new different assay systems for thyrotropin receptor antibodies with reference to thyroid-stimulating antibodies and thyroid stimulation-blocking antibodies in Graves' disease.
Hirooka Y; Li C; Takagi J; Gotoh M; Habu S; Yasaka-Nomura T; Ishihara R; Nakasone Y; Nakamura R; Morikawa R; Otake K; Nogimori T; Ishizuki Y
Int J Clin Pharmacol Res; 2004; 24(4):111-6. PubMed ID: 15754915
[TBL] [Abstract][Full Text] [Related]
19. Radioiodine therapy for hyperthyroidism.
Villagelin D; Santos RB; Romaldini JH
N Engl J Med; 2011 May; 364(20):1978; author reply 1978-9. PubMed ID: 21591960
[No Abstract] [Full Text] [Related]
20. [Transient neonatal hyperthyroidism caused by transplacental transport of pituitary TSH receptor antibodies].
Thibault H; Breton D; Brauner R
Arch Fr Pediatr; 1993; 50(7):581-3. PubMed ID: 8002722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
